Transcriptional repressor ZEB2 promotes terminal differentiation of CD8+ effector and memory T cell populations during infection
Kyla Omilusik(Fate Therapeutics (United States)), Ananda W. Goldrath(University of California San Diego), Agata Stryjewska(KU Leuven), Steven Goossens(Ghent University), Christiane Zweier(University Hospital of Bern), Lynne M. Bird(University of California San Diego), Hisato Kondoh(Kyoto Sangyo University), Rahul Roychoudhuri(University of Cambridge), Danny Huylebroeck(Erasmus MC), Jessica Nguyen(University of California San Diego), Luca Gattinoni(National Cancer Institute), Bingfei Yu(University of California San Diego), Alexander Weidemann(Krankenhaus Köln-Holweide), J. Adam Best(University of California San Diego), Jody J. Haigh(Institute of Cell Biology), Yujiro Higashi(The University of Osaka), Eve Seuntjens(VIB-KU Leuven Center for Brain & Disease Research)
Cited by 258
Related Papers
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
|Journal of Clinical Investigation|2005|949
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
|Journal of Clinical Investigation|2013|930
Biology of HIF-1α
|Cell Death and Differentiation|2008|923
Selecting and maintaining a diverse T-cell repertoire
|Nature|1999|715